An evolving landscape: EGFR-mutant NSCLC management updates from September 2022

Learning objective:         

After watching this broadcast, participants should be able to:

• Discuss data from September 2022 to further expand on strategies for the management of EGFR-mutant NSCLC
• Evaluate how these data can be applied in clinical practice

Faculty:

• Matthew Krebs (UK)
• Antonio Passaro (Italy)
• Michael Thomas (Germany)
• Rosario Garcia Campelo (Spain)

 

Claim your CPD credits
The content of the following has been certified by the CPD Certification Service as conforming to continuing professional development principles.

You can claim 1.0 credits for this activity.
Please make a note of the below information to claim your points.

Name of activity: Janssen Oncology Medical Education Webinar (OME) An evolving landscape: EGFR+ NSCLC management updates from September 2022
Certificate number: A032957
Date of activity: October 2022
CPD Provider: Sciterion 013096